Cerebral Palsy, Spastic Quadriplegic, 2
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy.
|
16301218 |
2005 |
Cerebral Palsy, Spastic Quadriplegic, 2
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Nephrotic Syndrome
|
0.320 |
GeneticVariation
|
group |
BEFREE |
Mutations in KANK proteins are implicated in cancers and genetic diseases, such as nephrotic syndrome.
|
29217769 |
2018 |
Nephrotic Syndrome
|
0.320 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Here, using homozygosity mapping and whole-exome sequencing, we identified recessive mutations in kidney ankyrin repeat-containing protein 1 (KANK1), KANK2, and KANK4 in individuals with nephrotic syndrome.
|
25961457 |
2015 |
Nephrotic Syndrome
|
0.320 |
GeneticVariation
|
group |
BEFREE |
Here, using homozygosity mapping and whole-exome sequencing, we identified recessive mutations in kidney ankyrin repeat-containing protein 1 (KANK1), KANK2, and KANK4 in individuals with nephrotic syndrome.
|
25961457 |
2015 |
Alcoholic Intoxication, Chronic
|
0.310 |
Biomarker
|
disease |
PSYGENET |
In addition, several SNPs of these loci (ANAPC1, KANK1, NACM1, TCC12, SLCO3A1 and ZCCHC14) were associated with alcohol dependence.
|
22377092 |
2012 |
Alcoholic Intoxication, Chronic
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
In addition, several SNPs of these loci (ANAPC1, KANK1, NACM1, TCC12, SLCO3A1 and ZCCHC14) were associated with alcohol dependence.
|
22377092 |
2012 |
Cholestasis
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Integrative ""-Omics"" Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis."
|
27989131 |
2016 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Cerebral Palsy, Spastic Quadriplegic, 1
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy.
|
16301218 |
2005 |
Cerebral Palsy
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
These data led us to conclude that small deletions involving KANK1 do not cause a highly-penetrant influence of large effect size and they are unlikely to contribute significantly to the aetiology of disease in patients with development delay, intellectual disability, autism or cerebral palsy.
|
30684669 |
2020 |
Cerebral Palsy
|
0.150 |
Biomarker
|
disease |
BEFREE |
After evaluation of our case series and reconsideration of the literature, we propose that KANK1 aberrations do not frequently cause CP but cannot exclude that they represent a risk factor for ASD, especially when the coding region of the shorter, alternate KANK1 transcript (termed "transcript 4" in the UCSC Genome Browser) is impacted.
|
29729439 |
2019 |
Cerebral Palsy
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Deletion of the KANK1 gene (also called ANKRD15), located at chromosome position 9p24.3, has been associated with neurodevelopmental disease including congenital cerebral palsy, hypotonia, quadriplegia, and intellectual disability in a four-generation family.
|
23454270 |
2013 |
Cerebral Palsy
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Previous studies have identified mutations in the actin-capping protein KANK1 and the adaptor protein-4 complex in forms of inherited cerebral palsy, suggesting a role for components of the dynamic cytoskeleton in the genesis of the disease.
|
23836506 |
2013 |
Cerebral Palsy
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy.
|
16301218 |
2005 |
Cerebral Palsy
|
0.150 |
Biomarker
|
disease |
HPO |
|
|
|
Intellectual Disability
|
0.110 |
GeneticVariation
|
group |
BEFREE |
Deletion of the KANK1 gene (also called ANKRD15), located at chromosome position 9p24.3, has been associated with neurodevelopmental disease including congenital cerebral palsy, hypotonia, quadriplegia, and intellectual disability in a four-generation family.
|
23454270 |
2013 |
Intellectual Disability
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
These results supported that upregulation of KANK1 works as a tumour suppressor gene in BC and is associated with improved patients' outcomes.
|
31679074 |
2020 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Meanwhile, Kank1 also plays a key role in the occurrence and development of various types of tumors, suggesting that Kank1 may be an anti-oncogene.
|
31338836 |
2020 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Basal cell carcinoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
Uterine Fibroids
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.
|
31649266 |
2019 |
Basal Cell Neoplasm
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
Basal Cell Cancer
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |